The Nucleic Acid Amplification Testing (NAAT) Market is expanding as hospitals, diagnostic laboratories, and public health agencies shift toward rapid, high-sensitivity molecular diagnostics for early disease detection and targeted treatment. Growth is supported by rising infectious disease prevalence, expansion of point-of-care (POC) testing platforms, oncology biomarker screening, and...
The Global Genomics Market is experiencing substantial growth as advances in genetic research, sequencing technologies, and molecular diagnostics transform healthcare and life sciences. Genomics involves the study of an organism’s complete DNA, including the interactions and functions of genes. Its applications span disease diagnosis, personalized medicine, drug discovery, agricultural...
The global Percutaneous Coronary Intervention (PCI) Devices Market is shaped by changing healthcare requirements and the growing demand for minimally invasive cardiovascular procedures. Polaris Market Research has prepared this report to provide an overview of the industry and its expected development over the coming years. It examines the factors influencing market activity and explains how...
The global Magnetic Resonance Imaging (MRI) market is experiencing steady expansion as healthcare providers increasingly rely on advanced diagnostic imaging for disease detection, assessment, and treatment planning. The market encompasses MRI systems used across hospitals, diagnostic centers, and other healthcare settings, with applications spanning oncology, neurology, cardiology,...
The Global Vinca Alkaloid Market is witnessing steady growth, driven by the increasing use of plant-derived alkaloids in cancer treatment and the continued development of oncology therapeutics. Vinca alkaloids are an important class of antineoplastic agents used in chemotherapy, particularly for treating various hematological malignancies and solid tumors. Their established role in cancer care...
The global Cell and Gene Therapy Market is expanding as pharmaceutical and biotechnology companies increase their focus on advanced treatments for chronic diseases, genetic disorders, oncology, rare diseases, and personalized medicine. Increasing research activity, biotechnology investments, regulatory support, and technological innovation are contributing to the development and adoption of...
The global Injectable Drug Delivery Market is witnessing steady expansion as injectable therapies become increasingly important across chronic diseases, acute conditions, and emergency care. The market size is projected to reach 84.08 billion by 2031 from 48.89 billion in 2024, registering a CAGR of 8.2% during 2025–2031. The growth reflects increasing demand for injectable therapies, the...
The global High Content Screening Market is experiencing significant growth as pharmaceutical companies, biotechnology organizations, and research institutions increasingly focus on advanced drug discovery and cellular analysis technologies. The market was valued at US$ 764.40 million in 2025 and is projected to reach US$ 1,642.20 million by 2034, registering a compound annual growth rate of...
"According to the latest report published by Data Bridge Market Research, the Molecular Point of Care Testing (using NAAT) Market
CAGR Value
As per Data Bridge Market Research Analysis the global molecular point of care testing (using NAAT) market size was valued at USD 37.93 billion in 2024 and is expected to reach USD 86.17 billion by 2032, at a CAGR of 1.08%...
The global epigenetics market is experiencing significant growth as advancements in genomic research, increasing cancer prevalence, and the expanding adoption of personalized medicine create new opportunities across healthcare and biotechnology industries. The epigenetics market size is projected to reach US$ 35.84 billion by 2031 from US$ 11.12 billion in 2024. The market is expected to...
The Global NGS Sample Preparation Market is expected to reach US$ 6,059 million by 2031. The market is anticipated to register a CAGR of 12.3% during 2025–2031. Increasing adoption of next-generation sequencing (NGS) technologies, growing demand for precision medicine, rising genomic research activities, and advancements in molecular diagnostics are driving market expansion. NGS sample...
The Gemcitabine Hydrochloride market was valued at US$ 873.1 million in 2025 and is expected to reach US$ 1,297.83 million by 2034. The market is estimated to record a CAGR of 4.5% during 2026–2034. The increasing prevalence of cancer, rising demand for effective chemotherapy medications, growing awareness of early cancer diagnosis, and expanding access to oncology treatments are among...